Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Shield Therapeutics
Shield Therapeutics
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Accrufer
Ferric maltol
2019-07-25
2031-2035
Iron-deficiency anemia
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Ferric maltol
iron-deficiency anemia
,
iron deficiencies
,
anemia
,
inflammatory bowel diseases
,
intestinal diseases
,
deficiency diseases
,
crohn disease
,
chronic renal insufficiency
,
kidney diseases
,
renal insufficiency
,
ulcerative colitis
,
colitis
,
ulcer
Ademetionine
anemia
,
iron-deficiency anemia
,
iron deficiencies
Aspartame
anemia
,
iron-deficiency anemia
,
iron deficiencies
Fcm
crohn disease
,
anemia
,
inflammatory bowel diseases
,
intestinal diseases
,
iron-deficiency anemia
,
iron deficiencies
Evidence
anemia
,
iron-deficiency anemia
,
iron deficiencies
Mydfrin
iron-deficiency anemia
,
iron deficiencies
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use